Trial intelligence / Profile preview

Ezetimibe and Fenofibrate Coadministration in Mixed Hyperlipidemia

NCT00092573Phase 3Completed

Sponsor
Organon & Co.
Start
Apr 2003
Primary completion
Nov 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of ezetimibe in mixed hyperlipidemia, sponsored by Organon & Co.. Started Apr 2003; status: completed.

02

Drugs

ezetimibe
03

Conditions

mixed hyperlipidemia

Beyond the preview

Go deeper on NCT00092573.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00092573.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call